Trial Profile
LOW DOSE THROMBOLYSIS, ULTRASOUND ASSISTED THROMBOLYSIS OR HEPARIN FOR INTERMEDIATE HIGH RISK PULMONARY EMBOLISM
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2019
Price :
$35
*
At a glance
- Drugs Alteplase (Primary) ; Heparin; Low molecular weight heparins
- Indications Pulmonary embolism
- Focus Therapeutic Use
- Acronyms STRATIFY
- 06 Sep 2018 New trial record